It is getting a bit quiet with PromarkerD, I grow a tad nervous as each day passes.
Another SGLT2-inhibitor drug completed a successful trial:
https://www.reuters.com/article/us-astrazeneca-study/astrazeneca-scores-win-as-diabetes-drug-shown-to-slow-kidney-disease-idUSKBN21H0KY
AstraZeneca’s diabetes treatment Farxiga has proven to be “overwhelmingly” effective at slowing chronic kidney disease ahead of the scheduled end of a drug trial, the British drugmaker said
Regarding Janssen presentation this weekend., page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.020(5.06%) |
Mkt cap ! $62.19M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 37.5¢ | $53.53K | 141.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 7706 | 4 |
View Market Depth
| Last trade - 11.22am 28/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |